GeneDx Holdings Cost of Goods Sold 2020-2025 | WGS
GeneDx Holdings cost of goods sold from 2020 to 2025. Cost of goods sold can be defined as the difference between beginning and ending inventories for tangible products resulting in an expense that reflects production and sales costs.
| GeneDx Holdings Annual Cost of Goods Sold (Millions of US $) |
|
|---|---|
| 2024 | $111 |
| 2023 | $113 |
| 2022 | $261 |
| 2021 | $229 |
| 2020 | $175 |
| 2019 | $113 |
| GeneDx Holdings Quarterly Cost of Goods Sold (Millions of US $) |
|
|---|---|
| 2025-03-31 | $29 |
| 2024-12-31 | $29 |
| 2024-09-30 | $29 |
| 2024-06-30 | $28 |
| 2024-03-31 | $25 |
| 2023-12-31 | $27 |
| 2023-09-30 | $28 |
| 2023-06-30 | $30 |
| 2023-03-31 | $28 |
| 2022-12-31 | $78 |
| 2022-09-30 | $70 |
| 2022-06-30 | $66 |
| 2022-03-31 | $48 |
| 2021-12-31 | $61 |
| 2021-09-30 | $51 |
| 2021-06-30 | $48 |
| 2021-03-31 | $69 |
| 2020-12-31 | |
| 2020-09-30 | $37 |
| 2019-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $1.974B | $0.305B |
| GeneDx Holdings Corp. is at the forefront of transforming healthcare through its industry-leading exome and genome testing and interpretation, fueled by rare disease data sets. GeneDx Holdings Corp., formerly known as Sema4 Holdings Corp., is based in STAMFORD, Conn. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $137.516B | 25.79 |
| Elevance Health (ELV) | United States | $86.906B | 11.21 |
| CVS Health (CVS) | United States | $79.797B | 9.92 |
| Cencora (COR) | United States | $55.901B | 19.45 |
| DiDi Global (DIDIY) | China | $23.062B | 35.00 |
| Natera (NTRA) | United States | $22.600B | 0.00 |
| BioMerieux (BMXMF) | France | $16.097B | 0.00 |
| Solventum (SOLV) | United States | $13.040B | 13.80 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.997B | 0.00 |
| CochLear (CHEOY) | Australia | $11.519B | 0.00 |
| ICON (ICLR) | Ireland | $10.888B | 10.12 |
| Doximity (DOCS) | United States | $10.770B | 49.86 |
| Revvity (RVTY) | United States | $10.667B | 18.36 |
| Viatris (VTRS) | United States | $9.929B | 3.41 |
| HealthEquity (HQY) | United States | $9.746B | 42.69 |
| Avantor (AVTR) | United States | $8.825B | 12.82 |
| Medpace Holdings (MEDP) | United States | $8.438B | 22.41 |
| Sonic Healthcare (SKHHY) | Australia | $8.340B | 0.00 |
| Charles River Laboratories (CRL) | United States | $6.935B | 13.59 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.103B | 24.19 |
| BrightSpring Health Services (BTSG) | United States | $4.095B | 37.90 |
| Sotera Health (SHC) | United States | $3.460B | 19.66 |
| Surgery Partners (SGRY) | United States | $2.969B | 38.62 |
| Alignment Healthcare (ALHC) | United States | $2.926B | 0.00 |
| Concentras Parent (CON) | United States | $2.786B | 16.10 |
| Organon (OGN) | United States | $2.389B | 2.54 |
| Ardent Health Partners (ARDT) | United States | $2.110B | 8.99 |
| Premier (PINC) | United States | $1.904B | 14.45 |
| Progyny (PGNY) | United States | $1.831B | 40.30 |
| PACS (PACS) | United States | $1.579B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.507B | 30.14 |
| Teladoc Health (TDOC) | United States | $1.216B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.196B | 9.10 |
| Establishment Labs Holdings (ESTA) | $1.099B | 0.00 | |
| CareDx (CDNA) | United States | $1.045B | 16.31 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.011B | 0.00 |
| Agilon Health (AGL) | United States | $0.869B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.769B | 7.20 |
| QDM (QDMI) | Hong Kong, SAR China | $0.755B | 0.00 |
| Nutex Health (NUTX) | United States | $0.686B | 10.38 |
| Embecta (EMBC) | United States | $0.583B | 3.93 |
| LifeMD (LFMD) | United States | $0.549B | 0.00 |
| Enhabit (EHAB) | United States | $0.545B | 44.83 |
| InnovAge Holding (INNV) | United States | $0.536B | 0.00 |
| SBC Medicals (SBC) | United States | $0.529B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.486B | 10.93 |
| Sonida Senior Living (SNDA) | United States | $0.462B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.424B | 0.00 |
| Oncology Institute (TOI) | United States | $0.249B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.235B | 0.00 |
| Beauty Health (SKIN) | United States | $0.202B | 0.00 |
| KindlyMD (KDLY) | United States | $0.150B | 0.00 |
| DocGo (DCGO) | United States | $0.146B | 23.83 |
| KindlyMD (NAKA) | United States | $0.097B | 0.00 |
| So-Young (SY) | China | $0.092B | 0.00 |
| OncoCyte (OCX) | United States | $0.085B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.072B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.072B | 0.00 |
| NeueHealth (NEUE) | United States | $0.060B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.060B | 0.00 |
| ModivCare (MODV) | United States | $0.060B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.059B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.056B | 0.00 |
| Biodesix (BDSX) | United States | $0.041B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.029B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.011B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |